I think most of the volume on this now is coming from those who see a cheap, FDA approved stock and jump in without doing much/any DD. When they realize they bought a pet rock they sell, thus false volume.
I have two hopes: first-- an investor suit is filed against them. I think it has probably been too long for that though, and realistically, I haven't suffered enough loss to get tied up in that.
Second-- the board gets tired of messing with this and sells the company. If sales have been decent/growing, then it might justify a price between $1-2, as long as they haven't screwed up their relationship with Abbott. Could possibly bring more, since they have a FDA CRL on a submission that-- if memory serves-- could be re-filed without a pot load of work. Now that I think of it, might be interesting to do a FDA search for the company to see if there have been submissions over the past couple of years.
Third-- everything stays the way it is. It is not inconceivable that the company is doing quite well. Their test was approved and incorporated on Abbott's Assay device, and there were other companies that were working to that end. I could see the directors sitting there paying themselves well, and riding this horse till it drops. Since the company is dark we wouldn't know until the very end.
These are the scenarios I can see.
Good luck to you! I will continue to hold, as I don't really need the write off this year.
******************************************************************
just my opinions, of course
News 
Market Data 
Discover 
